Biotech BioNxt Reports “Intention to Grant” Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies November 4, 2025
Biotech BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization October 30, 2025
Featured News BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug October 22, 2025
Featured News Wisp & Vesalius Forge Women-Centric Longevity Path With Peptide Therapy Launch October 17, 2025
Biotech BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease June 13, 2025
Biotech BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team June 10, 2025
Biotech BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025 June 9, 2025
Search
biotech etf
